Unibio CIS ApS: Financial statements 2018
CVR: 37456136
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Unibio CIS ApS (CVR 37456136) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -341,000 and a net result of DKK -263,000 compared with DKK 18,000 the year before. Equity in the 2018 report amounted to DKK 42,000. The solvency ratio was 1.9%.
- Gross Profit
- DKK -341,000
- Profit/Loss
- DKK -263,000
- Equity
- DKK 42,000
- Total Assets
- DKK 2,251,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -341 t. | -263 t. | 42 t. | 0 |
| 2017 | - | 94 t. | 18 t. | 305 t. | - |
| 2016 | - | 279 t. | 237 t. | 287 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of June 15, 2018, Jakob Brix Christensen is registered as director of Unibio CIS ApS.
As of June 15, 2018, Jesper Halling Pedersen has stepped down as director of Unibio CIS ApS.
Unibio CIS ApS has published its annual report for 2017. Gross profit came to DKK 94,000, and the net result was DKK 18,000.
About Unibio CIS ApS
Unibio CIS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named UniBio Russia ApS. The management consists of Søren Olrik Eklund and Jess Dragheim. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 2,100,000 and a net result of DKK 2,068,000 compared with DKK -2,197,000 the year before. Equity in the 2025 report amounted to DKK 2,417,000.